This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Kopin, Cardionet: Early Volume Plays

NEW YORK (TheStreet) -- Several small-cap stocks were poised to move on above-average volume during Monday's session

Art Technology Group (ARTG) rose by 18 cents, or 4.4%, to $4.30 in the premarket session after the company filed for a $250 million mixed shelf offering. The three-month average daily volume for Art Technology is 1.3 million, according to Yahoo! Finance.

Kopin (KOPN) jumped by 56 cents, or 12.6%, to $5 in the premarket session after the company reported third-quarter earnings of 13 cents a share, beating the single analyst estimate of 4 cents a share. Revenue climbed 4% from a year ago to $32 million, also better than the lone estimate. Kopin also offered full-year revenue guidance that was better than the single forecast. The three-month average daily volume for Kopin is 386,000, according to Yahoo! Finance.

Cardionet (BEAT) fell by 41 cents, or 6.9%, to $5.50 in the premarket session after the company said it was disappointed that the Centers for Medicare and Medicaid Services hasn't established a national pricing reimbursement rate for mobile cardiovascular telemetry in the Medicare final rule for the physician fee schedule for 2010. Reimbursement for mobile cardiovascular telemetry will continue to be carrier priced by Highmark Medicare Services, the company said. The three-month average daily volume for Cardionet is 996,000, according to Yahoo! Finance.

AEterna Zentaris (AEZS) rose by 8 cents, or 7.8%, to $1.10 in the premarket session after the company announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108, in patients with platinum-resistant and taxane-pretreated ovarian cancer.. The three-month average daily volume for AEterna Zentaris is 1.1 million, according to Yahoo! Finance.

BioForm Medical (BFRM) added 18 cents, or 5%, to $3.80 in the premarket session after the company reported a smaller-than-expected loss of a penny a share, compared to estimates the company would lose 7 cents a share in the quarter. Revenue climbed 16.6% from a year ago to $18.3 million, also topping estimates. BioForm also offered a rosy outlook for full-year 2010. The three-month average daily volume for BioForm is 111,000, according to Yahoo! Finance.

Huntington Bancshares (HBAN) gained 9 cents, or 2.4%, to $3.90 in the premarket session after the bank said it has chosen to continue its participation in the Federal Deposit Insurance Corp.'s Transaction Account Guarantee Program. The three-month average daily volume for Huntington is 26.7 million, according to Yahoo! Finance.

-- Written by Robert Holmes in New York.

Check out all of Monday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,494.98 -6.67 -0.04%
S&P 500 1,873.86 -1.53 -0.08%
NASDAQ 4,120.3330 -6.6340 -0.16%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs